AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.090

+0.00911.11%

Volume:195.87K

Turnover:17.25K

Market Cap:33.13M

PE:-4.49

High:0.090

Open:0.083

Low:0.083

Close:0.081

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:1.10

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-273.29%

ROA:-50.29%

PB:-40.09

PE(LYR):-4.50

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BCAL Diagnostics Launching Cancer Detection Test in Australia; Shares Rise 4%

MT Newswires Live

BCAL Diagnostics Ltd - Introduces Avantect Multi-Cancer Early Detection Test

THOMSON REUTERS

BCAL Diagnostics - Comments Attributed in Article Refer to Views of Some Fund Managers Who Have Been Advocating for a Three-Way Merger

THOMSON REUTERS

BCAL Diagnostics Ltd - Comments were not Made on Behalf of Bcal

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BDX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.09,"timestamp":1790748720000,"preClose":0.081,"halted":0,"volume":195868,"delay":0,"changeRate":0.11111111111111104,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.020055,"marketStatus":"Not Yet Opened","change":0.009,"latestTime":"09-30 16:12:00 AEST","open":0.083,"high":0.09,"low":0.083,"amount":17252,"amplitude":0.08642,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.020055,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.081,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":1.1048523292321286,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BDX.AU","preClose":0.081,"auctionPrice":0.09,"auctionVolume":50000,"auction":3,"marketStatus":"盘后竞价","timestamp":1790748458590}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-50.29%","roe":"-273.29%","lyrEps":-0.02,"volumeRatio":1.1048523292321286,"shares":368067640,"dividePrice":0,"high":0.09,"amplitude":0.08642,"preClose":0.081,"low":0.083,"week52Low":0.052,"pbRate":"-40.09","psRate":"14.08","week52High":0.155,"institutionHeld":0,"latestPrice":0.09,"eps":-0.020055,"divideRate":0,"volume":195868,"delay":0,"ttmEps":-0.020055,"open":0.083,"prevYearClose":0.105,"prevWeekClose":0.081,"prevMonthClose":0.09,"prevQuarterClose":0.09,"fiveDayClose":0.082,"twentyDayClose":0.068,"sixtyDayClose":0.071},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-03","symbol":"BDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788393600000,"name":null,"time":"","dateTimestamp":1788357600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669179767","title":"BCAL Diagnostics Launching Cancer Detection Test in Australia; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179767","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179767?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:22","pubTimestamp":1790130174,"startTime":"0","endTime":"0","summary":"BCAL Diagnostics  is launching its Avantect multi-cancer early detection test in Australia, with an initial rollout in Sydney and Melbourne ahead of a broader national release, according to a Wednesday filing with the Australian bourse.The blood test looks for cancer-associated signals across eight cancer types, including lung, pancreatic, liver, ovarian, gastric, esophageal, breast, and colorectal cancer, to provide a likely organ-of-origin signal, per the filing.In a case-controlled validation study, the test showed overall sensitivity of 56.2% and specificity of 98.4% across all the analyzed cancers, the company said.Its shares rose 4% in recent Wednesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7067","VAS.AU","QFN.AU","VAP.AU","E200.AU","OZR.AU","QRE.AU","IISV.AU","OZF.AU","BEAR.AU","IIGF.AU","DACE.AU","EIGA.AU","BDX.AU","IMLC.AU","GIVE.AU","XKO.AU","SLF.AU","XJO.AU","BBOZ.AU","STW.AU","GEAR.AU","ZYAU.AU","IOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669755481","title":"BCAL Diagnostics Ltd - Introduces Avantect Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669755481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669755481?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:44","pubTimestamp":1790124288,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0OS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554179","title":"BCAL Diagnostics - Comments Attributed in Article Refer to Views of Some Fund Managers Who Have Been Advocating for a Three-Way Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554179?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:20","pubTimestamp":1789010413,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4511BP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554171","title":"BCAL Diagnostics Ltd - Comments were not Made on Behalf of Bcal","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554171?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:20","pubTimestamp":1789010413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4511BP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":14,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BDX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}